source
- China unveils new five-year plan to boost biotech and pharma and compete globallyChina's government released its latest five-year plan aimed at expanding the country's biotech and pharmaceutical sectors. The document outlines a strategy to strengthen research, development and m…
- Alkermes reports promising Phase 1b results for orexin agonist ALKS 7290 in ADHDAlkermes presented data from a Phase 1b study that evaluated its orexin-based compound ALKS 7290 in adults with attention-deficit/hyperactivity disorder. The trial enrolled 50 participants who rece…